Buch, Englisch, 457 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 955 g
Buch, Englisch, 457 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 955 g
ISBN: 978-3-030-64008-8
Verlag: Springer International Publishing
This unique handbook comprises very practical structured descriptions of more than 10 new agents used in treatment of melanomas and skin carcinomas together with biological background of their mechanisms of action. It provides structured and up-to-date information about all therapeutics in cutaneous malignancies, making it extremely useful in clinical practice, for clinicians that need timely and focused information.
Prepared by a group of international authors from expert melanoma centres in Europe, the book provides knowledge distilled from the diverse perspectives of the contributing authors (pathologists, translational scientists and clinicians). This book is of interest to medical oncologists, oncological surgeons, dermatologists and immunologists as well as biologists and pharmacologists.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Dermatologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
Weitere Infos & Material
Part 1. Pathological, molecular and immunological background of Cutaneous MalignanciesPathology of Melanoma and Skin Carcinomas Molecular Landscape Profile of MelanomaMolecular Landscape of Skin CarcinomasImmunological Features of MelanomaPart 2. Targeted Therapies in Skin CancersDabrafenib and TrametinibVemurafenib and CobimetinibEncorafenib and BinimetinibVismodegibSonidegibPart 3. Immunological Strategies in Advanced MelanomaIpilimumabNivolumabPembrolizumabTalimogene LeharparepvecPart 4. Future of Melanoma ImmunotherapyPerspectives of Immunotherapy in Advanced Melanoma Combinations and SequencingPart 5. Immunological Therapies in Advanced Skin CarcinomasAvelumabCemiplimabPerspectives of Immunotherapy in Non-Melanoma Skin CancersPart 6. Mechanism of Resistance to TherapyMechanisms of Resistance to Targeted Therapies in Skin CancerMechanisms of Resistance to ImmunotherapyPart 7. Perioperative Therapy of MelanomaNeoadjuvant and Adjuvant Therapy in MelanomaPart 8. Special Techniques and PopulationsAdoptive Cell TherapyImmunological Therapies in Special Populations: HIV, Hepatitis and Organ TransplantationConclusions